Ivy Foundation Translational Adult Glioma Grant Award 2021

Program Description

The Ben & Catherine Ivy Foundation Emerging Adult Glioma Award provides grant support to investigators conducting high-impact, high-reward translational research for glioma. This award is intended to support projects designed to contribute to identifying therapies that will impact the survival of patients with brain cancer.

Eligibility

• A PhD, MD or equivalent is required.
• Only one submission per applicant is permitted every calendar year.
• Applicants need not be U.S. citizens, but must be employed by a U.S. non-profit academic institution.
• The Ben & Catherine Ivy Foundation does not discriminate on the basis of race, color, religion, national origin, sex, gender identity, sexual orientation, age, disability or any other legally protected characteristics.

Award Terms

• $600,000 total, payments received at initiation and completion of project
• Project duration is 24 months
• Indirect costs not to exceed 10% (included in award total)

Key Dates

• March 1, 2021: Application Due Date (Please do not submit before January 1, 2021)
• May 1, 2021: Selection of Awardees
• June 15, 2021: Signed Agreements Due
• July 1, 2021: Award Start Date

Application Information Required

• Contact Information (name, phone, address, email, and assistant contact information)
• Project Title
• Project Description
  • 4 page maximum including graphs, photos, etc.
  • Minimum 10-point font size
• Principal Investigator’s Biography
  • 6 page maximum
  • NIH Biosketch
• List of All Current Funding 
  • 50-word project description, affiliated parties, and direct costs per year